Keywords: GlaxoSmithKline, Response Genetics, Equity stake, Share placing, Bayer, Teva, Animal helath business

M&A briefs: GlaxoSmithKline/Response Genetics; Bayer/Teva unit

Article | 16 September 2012

Print This

USA-based Response Genetics (Nasdaq: RGDX) last week entered into a purchase agreement with UK pharma giant GlaxoSmithKline (LSE: GSK) and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in